Protein kinase C and oxidative stress in an animal model of mania. 2012

Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
Laboratory of Neurosciences and National Institute for Translational Medicine, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil.

The present study aims to investigate the effects of protein kinase C using the inhibitor Tamoxifen (TMX) on oxidative stress in a rat animal model of mania induced by d-amphetamine (d-AMPH). In the reversal model, d-AMPH or saline (Sal) were administered to rats for 14 days, and between days 8-14, rats were treated with TMX or Sal. In the prevention model, rats were pretreated with TMX or Sal, and between days 8-14, d-AMPH or Sal were administrated. In both experiments locomotor activity and risk-taking behavior were assessed by open-field test and oxidative stress was measured in prefrontal, amygdala, hippocampus and striatum. The results showed that TMX reversed and prevented d- AMPH-induced behavioral effects. In addition, the d-AMPH administration induced oxidative damage in both structures tested in two models. The TMX was able to reverse and prevent this impairment, however in a way dependent of cerebral area and technique evaluated. These findings reinforce the hypothesis that PKC play an important role in the pathophysiology of BD and the need for the study of inhibitors of PKC as a possible target for treatment the BD.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
July 2020, Progress in neuro-psychopharmacology & biological psychiatry,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
February 2011, Journal of psychopharmacology (Oxford, England),
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
April 2019, Molecular neurobiology,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
February 2008, Life sciences,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
July 2021, Journal of psychiatric research,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
May 2000, Free radical biology & medicine,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
September 2006, Journal of psychiatry & neuroscience : JPN,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
November 2017, The international journal of neuropsychopharmacology,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
March 2017, International journal of molecular sciences,
Amanda Valnier Steckert, and Samira Silva Valvassori, and Francielle Mina, and Jéssica Lopes-Borges, and Roger Bitencourt Varela, and Flávio Kapczinski, and Felipe Dal-Pizzol, and João Quevedo
November 1993, American journal of respiratory cell and molecular biology,
Copied contents to your clipboard!